Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers

被引：0
作者：
Mattsson, Niklas [1 ]
Andreasson, Ulf [1 ]
Carrillo, Maria C. [2 ]
Persson, Staffan [1 ]
Shaw, Leslie M. [3 ]
Zegers, Ingrid [4 ]
Zetterberg, Henrik [1 ,5 ]
Blennow, Kaj [1 ]
机构：
[1] Univ Gothenburg, Sahlgrens Univ Hosp, Sahlgrenska Acad,Clin Neurochem Lab, Dept Psychiat & Neurochem,Inst Neurosci & Psychia, Molndal, Sweden
[2] Alzheimers Assoc, Dept Med & Sci Relat, Chicago, IL USA
[3] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[4] European Commiss, Joint Res Ctr, Inst Reference Mat & Measurements, Geel, Belgium
[5] UCL Inst Neurol, London, England
来源：
BIOMARKERS IN MEDICINE | 2012年 / 6卷 / 04期
关键词：
Alzheimer's disease; biomarkers; cerebrospinal fluid; proficiency testing; NEUROCHEMICAL DEMENTIA DIAGNOSTICS; MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; NATIONAL INSTITUTE; XMAP TECHNOLOGY; TAU-PROTEINS; RECOMMENDATIONS; PERFORMANCE; GUIDELINES;
D O I：
10.2217/BMM.12.41
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Cerebrospinal fluid (CSF) biomarkers are increasingly used for diagnosis of Alzheimer's disease in research, clinical trials and clinical settings. As for other biochemical measurements, variability between laboratories for these biomarkers may be monitored by proficiency testing programs, where participating laboratories use their local routine methods to analyze test samples shipped from a central laboratory. In this review, we summarize the results from the last years' pilot proficiency programs and describe the ongoing standardization efforts in this area. Global proficiency testing for CSF biomarkers is now fully established. It will continue to play an important part in the standardization of measurements that is a prerequisite for the broad-scale future implementation of CSF biomarkers.
引用
收藏
页码：401 / 407
页数：7
相关论文
共 50 条
[21]   Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease [J].
Fagan, Anne M. ;
Perrin, Richard J. .
BIOMARKERS IN MEDICINE, 2012, 6 (04) :455-476
[22]   Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease [J].
Zetterberg, Henrik ;
Lunn, Michael P. ;
Herukka, Sanna-Kaisa .
BIOMARKERS IN MEDICINE, 2012, 6 (04) :371-376
[23]   Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment [J].
Parnetti, Lucilla ;
Eusebi, Paolo .
JOURNAL OF ALZHEIMERS DISEASE, 2018, 64 :S281-S287
[24]   Lights and Shadows of Cerebrospinal Fluid Biomarkers in the Current Alzheimer's Disease Framework [J].
Gallucci, Maurizio ;
Cenesi, Leandro ;
White, Celine ;
Antuono, Piero ;
Quaglio, Gianluca ;
Bonanni, Laura .
JOURNAL OF ALZHEIMERS DISEASE, 2022, 86 (03) :1061-1072
[25]   Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer's Disease [J].
Aksnes, Mari ;
Tiiman, Ann ;
Edwin, Trine Holt ;
Terenius, Lars ;
Bogdanovic, Nenad ;
Vukojevic, Vladana ;
Knapskog, Anne-Brita .
FRONTIERS IN AGING NEUROSCIENCE, 2021, 12
[26]   Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer's disease [J].
Alexopoulos, Panagiotis ;
Werle, Lukas ;
Roesler, Jennifer ;
Thierjung, Nathalie ;
Gleixner, Lena Sophie ;
Yakushev, Igor ;
Laskaris, Nikolaos ;
Wagenpfeil, Stefan ;
Gourzis, Philippos ;
Kurz, Alexander ;
Perneczky, Robert .
ALZHEIMERS RESEARCH & THERAPY, 2016, 8
[27]   Comparison of Two Analytical Platforms in Cerebrospinal Fluid Biomarkers for the Classification of Alzheimer's Disease Spectrum with Amyloid PET Imaging [J].
Lim, Ho Jae ;
Park, Jung Eun ;
Kim, Byeong C. ;
Choi, Seong-Min ;
Song, Min-Kyung ;
Cho, Soo Hyun ;
Seo, Hyeon Jeong ;
Kim, Jahae ;
Song, Ho-Chun ;
Choi, Kyu Yeong ;
Lee, Jang Jae ;
Kim, Hoo-Won ;
Ha, Jung-Min ;
Song, Woo Keun ;
Park, Sung-Gyoo ;
Lee, Jung Sup ;
Lee, Kun Ho .
JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (03) :949-958
[28]   Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update [J].
del Campo, Marta ;
Mollenhauer, Brit ;
Bertolotto, Antonio ;
Engelborghs, Sebastiaan ;
Hampel, Harald ;
Simonsen, Anja Hviid ;
Kapaki, Elisabeth ;
Kruse, Niels ;
Le Bastard, Nathalie ;
Lehmann, Sylvain ;
Molinuevo, Jose L. ;
Parnetti, Lucilla ;
Perret-Liaudet, Armand ;
Saez-Valero, Javier ;
Saka, Esen ;
Urbani, Andrea ;
Vanmechelen, Eugeen ;
Verbeek, Marcel ;
Visser, Pieter Jelle ;
Teunissen, Charlotte .
BIOMARKERS IN MEDICINE, 2012, 6 (04) :419-430
[29]   Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A Multicenter Study in Spain [J].
Alcolea, Daniel ;
Martinez-Lage, Pablo ;
Izagirre, Andrea ;
Clerigue, Montserrat ;
Carmona-Iragui, Maria ;
Alvarez, Rosa Maria ;
Fortea, Juan ;
Balasa, Mircea ;
Morenas-Rodriguez, Estrella ;
Llado, Albert ;
Grau, Oriol ;
Blennow, Kaj ;
Lleo, Alberto ;
Molinuevo, Jose L. .
JOURNAL OF ALZHEIMERS DISEASE, 2014, 39 (04) :719-726
[30]   Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Sensitivity, Specificity and Potential for Clinical Use [J].
D'Abramo, Cristina ;
D'Adamio, Luciano ;
Giliberto, Luca .
JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (03) :1-39
12345